Valérie Bertaina‐Anglade

Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects

Rainer Rupprecht, Gerhard Rammes, Daniela Eser et al. · Science · 2009 · 319 citations

Drug Target, Biochemistry, Translocator Protein +14

BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology

Xavier Ligneau, David Perrin, Laurent Landais et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 233 citations

Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses

Ivan Jeanne Weiler, Chad Spangler, Anna Y. Klintsova et al. · Proceedings of the National Academy of Sciences · 2004 · 209 citations · Full text

Neurotransmitter, Molecular Biology, Neurotransmission +17

The object recognition task in rats and mice: A simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity

Valérie Bertaina‐Anglade, E. Enjuanes, D. Morillon et al. · Journal of Pharmacological and Toxicological Methods · 2006 · 166 citations

Safety Pharmacology, Cognitive Science, Behavioral Neuroscience +13

Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model

Valérie Bertaina‐Anglade, Christophe Drieu La Rochelle, Pierre‐Alain Boyer et al. · Behavioural Pharmacology · 2006 · 118 citations

Learned Helplessness Model, Psychopharmacology, Mental Health +19